Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
MMSI 
Merit Medical Systems Inc (MMSI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: MMSI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $102.5
1 Year Target Price $102.5
| 4 | Strong Buy |
| 5 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 18.52% | Avg. Invested days 48 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.95B USD | Price to earnings Ratio 42.78 | 1Y Target Price 102.5 |
Price to earnings Ratio 42.78 | 1Y Target Price 102.5 | ||
Volume (30-day avg) 10 | Beta 0.61 | 52 Weeks Range 78.12 - 111.45 | Updated Date 12/6/2025 |
52 Weeks Range 78.12 - 111.45 | Updated Date 12/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.95 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.02% | Operating Margin (TTM) 11.1% |
Management Effectiveness
Return on Assets (TTM) 4.28% | Return on Equity (TTM) 8.3% |
Valuation
Trailing PE 42.78 | Forward PE 21.28 | Enterprise Value 5426270003 | Price to Sales(TTM) 3.35 |
Enterprise Value 5426270003 | Price to Sales(TTM) 3.35 | ||
Enterprise Value to Revenue 3.67 | Enterprise Value to EBITDA 17.33 | Shares Outstanding 59290248 | Shares Floating 57912343 |
Shares Outstanding 59290248 | Shares Floating 57912343 | ||
Percent Insiders 2.22 | Percent Institutions 105.53 |
Upturn AI SWOT
Merit Medical Systems Inc
Company Overview
History and Background
Merit Medical Systems, Inc. was founded in 1987 by Fred P. Lampropoulos. It has grown through product development and acquisitions to become a global company focused on designing, developing, manufacturing, and distributing proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy.
Core Business Areas
- Cardiovascular: Products used in cardiology procedures, including angiography and intervention, focusing on access, closure, and diagnostic capabilities.
- Interventional Oncology and Critical Care: Devices for tumor embolization, biopsy, and fluid management, targeting cancer treatment and critical care support.
- Endoscopy: A range of devices for gastrointestinal procedures.
- Peripheral Intervention: Products for treating peripheral artery disease (PAD), including balloons and catheters.
Leadership and Structure
Fred P. Lampropoulos is the Chairman and CEO. The company has a typical corporate structure with various vice presidents and directors overseeing different departments and business units.
Top Products and Market Share
Key Offerings
- EmboSphere Microspheres: Embolization microspheres used in interventional oncology procedures. Market share is estimated to be between 5-10% of the embolization market. Competitors include Boston Scientific and Cook Medical.
- Radial Access Products: Including introducer sheaths, radial artery compression devices. Merit has a solid position in this market. Competitors include Terumo and Medtronic.
- Inflation Devices: Used in balloon angioplasty and stent delivery. Merit is a major player in inflation devices. Competitors include Boston Scientific and Medtronic.
- Biopsy Products: Used for tissue sampling. Merit is a player in biopsy products. Competitors include Becton Dickinson and Hologic.
Market Dynamics
Industry Overview
The medical device industry is characterized by technological innovation, regulatory scrutiny, and increasing demand driven by an aging population and growing prevalence of chronic diseases. The market is competitive, with both large multinational corporations and smaller specialized companies.
Positioning
Merit Medical is positioned as a company focused on providing specialized and innovative solutions within interventional medicine. Its competitive advantages include a broad product portfolio, strong customer relationships, and a focus on niche markets.
Total Addressable Market (TAM)
The TAM for Merit Medical's core markets is estimated to be over $15 billion. Merit's positioning allows it to capture a significant portion of this market, particularly in specific niches like embolization and radial access.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Strong relationships with physicians
- Innovative product development
- Global distribution network
- Effective acquisition strategy
Weaknesses
- Dependence on key products
- Exposure to regulatory changes
- Integration risks from acquisitions
- Competition from larger players
- Supply chain vulnerabilities
Opportunities
- Expanding into emerging markets
- Developing new applications for existing technologies
- Acquiring complementary businesses
- Capitalizing on trends in minimally invasive procedures
- Strategic partnerships
Threats
- Increased competition
- Pricing pressures
- Product liability claims
- Economic downturns
- Changes in reimbursement policies
Competitors and Market Share
Key Competitors
- Boston Scientific (BSX)
- Medtronic (MDT)
- Becton Dickinson (BDX)
Competitive Landscape
Merit Medical competes with larger, more diversified medical device companies. Its advantages include a focus on specific niches and a strong customer network. Disadvantages include its smaller size and limited resources compared to larger competitors.
Major Acquisitions
Cianna Medical, Inc.
- Year: 2018
- Acquisition Price (USD millions): 200
- Strategic Rationale: Expanding Merit's breast care and biopsy portfolio.
Growth Trajectory and Initiatives
Historical Growth: Merit Medical has experienced growth through organic product development and strategic acquisitions. Historical growth rates vary depending on economic conditions and acquisition activity.
Future Projections: Future growth projections are typically based on analyst estimates and company guidance. These projections consider market trends, product pipeline, and competitive landscape.
Recent Initiatives: Recent initiatives include product launches, acquisitions of companies in complementary markets, and expansion into new geographies.
Summary
Merit Medical Systems demonstrates a solid presence in the interventional medical device market, marked by its niche-focused product portfolio and strong customer relationships. Its growth is fueled by product innovation and strategic acquisitions. However, Merit faces competition from larger industry players and potential regulatory hurdles. Overall, the company is well-positioned for continued growth, but careful navigation of competitive pressures and integration of acquisitions are critical.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Analyst reports
- Industry publications
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is approximate and may vary depending on the source. Financial data requires additional and current source of the companies SEC filings.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Merit Medical Systems Inc
Exchange NASDAQ | Headquaters South Jordan, UT, United States | ||
IPO Launch date 1990-08-09 | President, CEO & Director Ms. Martha Goldberg Aronson | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 7400 | Website https://www.merit.com |
Full time employees 7400 | Website https://www.merit.com | ||
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.